nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CACNA1G—epilepsy syndrome	0.142	0.402	CbGaD
Pimozide—CACNA1G—Trimethadione—epilepsy syndrome	0.068	0.176	CbGbCtD
Pimozide—OPRM1—epilepsy syndrome	0.0611	0.173	CbGaD
Pimozide—CHRM2—epilepsy syndrome	0.0517	0.147	CbGaD
Pimozide—CACNA1G—Zonisamide—epilepsy syndrome	0.034	0.0878	CbGbCtD
Pimozide—CYP2C19—epilepsy syndrome	0.0319	0.0904	CbGaD
Pimozide—HTR2A—epilepsy syndrome	0.0259	0.0733	CbGaD
Pimozide—CYP2D6—epilepsy syndrome	0.0237	0.0671	CbGaD
Pimozide—ABCB1—epilepsy syndrome	0.0169	0.0479	CbGaD
Pimozide—CYP2E1—Felbamate—epilepsy syndrome	0.00957	0.0247	CbGbCtD
Pimozide—CYP2E1—Trimethadione—epilepsy syndrome	0.00957	0.0247	CbGbCtD
Pimozide—CYP2E1—Clonazepam—epilepsy syndrome	0.00813	0.021	CbGbCtD
Pimozide—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.008	0.0207	CbGbCtD
Pimozide—CYP3A7—Carbamazepine—epilepsy syndrome	0.00669	0.0173	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00669	0.0173	CbGbCtD
Pimozide—CYP2E1—Rufinamide—epilepsy syndrome	0.00663	0.0171	CbGbCtD
Pimozide—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00645	0.0167	CbGbCtD
Pimozide—CYP3A7—Phenytoin—epilepsy syndrome	0.006	0.0155	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.006	0.0155	CbGbCtD
Pimozide—CYP2C19—Felbamate—epilepsy syndrome	0.006	0.0155	CbGbCtD
Pimozide—CYP2C19—Trimethadione—epilepsy syndrome	0.006	0.0155	CbGbCtD
Pimozide—ABCB1—Levetiracetam—epilepsy syndrome	0.00569	0.0147	CbGbCtD
Pimozide—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00564	0.0146	CbGbCtD
Pimozide—CYP2E1—Propofol—epilepsy syndrome	0.00541	0.014	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00535	0.0138	CbGbCtD
Pimozide—CYP3A7—Phenobarbital—epilepsy syndrome	0.00535	0.0138	CbGbCtD
Pimozide—CYP3A7—Midazolam—epilepsy syndrome	0.00528	0.0136	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00528	0.0136	CbGbCtD
Pimozide—CYP2E1—Phenobarbital—epilepsy syndrome	0.00517	0.0134	CbGbCtD
Pimozide—CYP2E1—Midazolam—epilepsy syndrome	0.00509	0.0132	CbGbCtD
Pimozide—CYP3A7—Diazepam—epilepsy syndrome	0.00507	0.0131	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00507	0.0131	CbGbCtD
Pimozide—CYP3A5—Carbamazepine—epilepsy syndrome	0.00502	0.013	CbGbCtD
Pimozide—CYP2E1—Diazepam—epilepsy syndrome	0.0049	0.0127	CbGbCtD
Pimozide—CYP2C19—Clobazam—epilepsy syndrome	0.00489	0.0126	CbGbCtD
Pimozide—CYP3A5—Phenytoin—epilepsy syndrome	0.0045	0.0116	CbGbCtD
Pimozide—CYP2C19—Carbamazepine—epilepsy syndrome	0.00405	0.0105	CbGbCtD
Pimozide—CYP3A5—Phenobarbital—epilepsy syndrome	0.00401	0.0104	CbGbCtD
Pimozide—CYP3A5—Midazolam—epilepsy syndrome	0.00396	0.0102	CbGbCtD
Pimozide—ABCB1—Clobazam—epilepsy syndrome	0.00394	0.0102	CbGbCtD
Pimozide—CYP3A5—Diazepam—epilepsy syndrome	0.00381	0.00983	CbGbCtD
Pimozide—ABCB1—Lamotrigine—epilepsy syndrome	0.0038	0.00981	CbGbCtD
Pimozide—CYP2C19—Primidone—epilepsy syndrome	0.00378	0.00977	CbGbCtD
Pimozide—CYP1A2—Carbamazepine—epilepsy syndrome	0.00374	0.00966	CbGbCtD
Pimozide—CYP2C19—Phenytoin—epilepsy syndrome	0.00363	0.00939	CbGbCtD
Pimozide—CYP1A2—Primidone—epilepsy syndrome	0.00349	0.00902	CbGbCtD
Pimozide—CYP2C19—Propofol—epilepsy syndrome	0.00339	0.00876	CbGbCtD
Pimozide—ABCB1—Carbamazepine—epilepsy syndrome	0.00327	0.00845	CbGbCtD
Pimozide—CYP2C19—Phenobarbital—epilepsy syndrome	0.00324	0.00837	CbGbCtD
Pimozide—CYP1A2—Propofol—epilepsy syndrome	0.00313	0.00808	CbGbCtD
Pimozide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00312	0.00806	CbGbCtD
Pimozide—CYP2C19—Diazepam—epilepsy syndrome	0.00307	0.00793	CbGbCtD
Pimozide—CYP3A5—Valproic Acid—epilepsy syndrome	0.003	0.00775	CbGbCtD
Pimozide—CYP2C19—Zonisamide—epilepsy syndrome	0.003	0.00774	CbGbCtD
Pimozide—CYP1A2—Phenobarbital—epilepsy syndrome	0.00299	0.00772	CbGbCtD
Pimozide—ABCB1—Phenytoin—epilepsy syndrome	0.00293	0.00758	CbGbCtD
Pimozide—CYP3A4—Felbamate—epilepsy syndrome	0.0029	0.00749	CbGbCtD
Pimozide—CYP3A4—Trimethadione—epilepsy syndrome	0.0029	0.00749	CbGbCtD
Pimozide—CYP1A2—Diazepam—epilepsy syndrome	0.00283	0.00732	CbGbCtD
Pimozide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00273	0.00704	CbGbCtD
Pimozide—ABCB1—Phenobarbital—epilepsy syndrome	0.00261	0.00675	CbGbCtD
Pimozide—ABCB1—Midazolam—epilepsy syndrome	0.00258	0.00666	CbGbCtD
Pimozide—CYP2D6—Propofol—epilepsy syndrome	0.00258	0.00666	CbGbCtD
Pimozide—ABCB1—Diazepam—epilepsy syndrome	0.00248	0.0064	CbGbCtD
Pimozide—CYP3A4—Clonazepam—epilepsy syndrome	0.00246	0.00637	CbGbCtD
Pimozide—CYP2C19—Valproic Acid—epilepsy syndrome	0.00242	0.00625	CbGbCtD
Pimozide—HTR2A—phrenic nerve—epilepsy syndrome	0.00237	0.0544	CbGeAlD
Pimozide—CYP3A4—Clobazam—epilepsy syndrome	0.00236	0.00611	CbGbCtD
Pimozide—CYP1A2—Valproic Acid—epilepsy syndrome	0.00223	0.00577	CbGbCtD
Pimozide—CYP2C19—Topiramate—epilepsy syndrome	0.00218	0.00564	CbGbCtD
Pimozide—CYP3A4—Rufinamide—epilepsy syndrome	0.00201	0.00519	CbGbCtD
Pimozide—CYP3A4—Carbamazepine—epilepsy syndrome	0.00196	0.00506	CbGbCtD
Pimozide—CYP3A4—Primidone—epilepsy syndrome	0.00183	0.00472	CbGbCtD
Pimozide—DRD3—telencephalic ventricle—epilepsy syndrome	0.0018	0.0413	CbGeAlD
Pimozide—CYP3A4—Phenytoin—epilepsy syndrome	0.00176	0.00454	CbGbCtD
Pimozide—CYP3A4—Propofol—epilepsy syndrome	0.00164	0.00423	CbGbCtD
Pimozide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00157	0.00405	CbGbCtD
Pimozide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00157	0.00405	CbGbCtD
Pimozide—CYP3A4—Midazolam—epilepsy syndrome	0.00154	0.00399	CbGbCtD
Pimozide—CYP3A4—Diazepam—epilepsy syndrome	0.00148	0.00383	CbGbCtD
Pimozide—CYP3A4—Zonisamide—epilepsy syndrome	0.00145	0.00374	CbGbCtD
Pimozide—CYP3A4—Valproic Acid—epilepsy syndrome	0.00117	0.00302	CbGbCtD
Pimozide—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00114	0.0262	CbGeAlD
Pimozide—HTR6—ganglion—epilepsy syndrome	0.00108	0.0248	CbGeAlD
Pimozide—HTR2A—locus ceruleus—epilepsy syndrome	0.00106	0.0243	CbGeAlD
Pimozide—CYP3A4—Topiramate—epilepsy syndrome	0.00106	0.00273	CbGbCtD
Pimozide—CALM2—pons—epilepsy syndrome	0.001	0.0231	CbGeAlD
Pimozide—CALM1—pons—epilepsy syndrome	0.001	0.023	CbGeAlD
Pimozide—CALM1—autonomic nervous system—epilepsy syndrome	0.000922	0.0212	CbGeAlD
Pimozide—HTR2A—cerebellar cortex—epilepsy syndrome	0.000862	0.0198	CbGeAlD
Pimozide—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000841	0.0193	CbGeAlD
Pimozide—CALM2—ear—epilepsy syndrome	0.000828	0.019	CbGeAlD
Pimozide—CALM1—ear—epilepsy syndrome	0.000824	0.0189	CbGeAlD
Pimozide—HTR2A—vagus nerve—epilepsy syndrome	0.000809	0.0186	CbGeAlD
Pimozide—DRD2—telencephalic ventricle—epilepsy syndrome	0.00076	0.0175	CbGeAlD
Pimozide—OPRM1—ganglion—epilepsy syndrome	0.000709	0.0163	CbGeAlD
Pimozide—HTR2A—pons—epilepsy syndrome	0.000609	0.014	CbGeAlD
Pimozide—CACNA1G—telencephalon—epilepsy syndrome	0.000605	0.0139	CbGeAlD
Pimozide—HTR2A—autonomic nervous system—epilepsy syndrome	0.000562	0.0129	CbGeAlD
Pimozide—HTR1A—ganglion—epilepsy syndrome	0.000524	0.012	CbGeAlD
Pimozide—CALM2—ganglion—epilepsy syndrome	0.000515	0.0118	CbGeAlD
Pimozide—CALM1—ganglion—epilepsy syndrome	0.000512	0.0118	CbGeAlD
Pimozide—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000501	0.0115	CbGeAlD
Pimozide—DRD2—ganglion—epilepsy syndrome	0.000473	0.0109	CbGeAlD
Pimozide—HTR6—forebrain—epilepsy syndrome	0.000452	0.0104	CbGeAlD
Pimozide—OPRK1—forebrain—epilepsy syndrome	0.000418	0.00962	CbGeAlD
Pimozide—HTR6—telencephalon—epilepsy syndrome	0.000415	0.00955	CbGeAlD
Pimozide—HTR1A—hindbrain—epilepsy syndrome	0.000397	0.00913	CbGeAlD
Pimozide—CALM2—hindbrain—epilepsy syndrome	0.00039	0.00898	CbGeAlD
Pimozide—CALM1—hindbrain—epilepsy syndrome	0.000388	0.00893	CbGeAlD
Pimozide—CACNA1G—head—epilepsy syndrome	0.000377	0.00867	CbGeAlD
Pimozide—DRD2—hindbrain—epilepsy syndrome	0.000359	0.00825	CbGeAlD
Pimozide—CACNA1G—nervous system—epilepsy syndrome	0.000357	0.00822	CbGeAlD
Pimozide—CACNA1G—central nervous system—epilepsy syndrome	0.000344	0.00791	CbGeAlD
Pimozide—CACNA1G—cerebellum—epilepsy syndrome	0.000336	0.00773	CbGeAlD
Pimozide—Flunarizine—CACNA1G—epilepsy syndrome	0.00033	0.126	CrCbGaD
Pimozide—HTR2A—ganglion—epilepsy syndrome	0.000312	0.00718	CbGeAlD
Pimozide—OPRM1—brainstem—epilepsy syndrome	0.000308	0.00709	CbGeAlD
Pimozide—OPRM1—forebrain—epilepsy syndrome	0.000297	0.00684	CbGeAlD
Pimozide—Flunarizine—CACNA1H—epilepsy syndrome	0.000297	0.113	CrCbGaD
Pimozide—OPRM1—telencephalon—epilepsy syndrome	0.000274	0.00629	CbGeAlD
Pimozide—CACNA1G—brain—epilepsy syndrome	0.000273	0.00628	CbGeAlD
Pimozide—CHRM2—forebrain—epilepsy syndrome	0.000271	0.00623	CbGeAlD
Pimozide—Fexofenadine—SLCO1A2—epilepsy syndrome	0.00027	0.103	CrCbGaD
Pimozide—DRD3—head—epilepsy syndrome	0.000269	0.00618	CbGeAlD
Pimozide—HTR6—head—epilepsy syndrome	0.000259	0.00595	CbGeAlD
Pimozide—DRD3—nervous system—epilepsy syndrome	0.000255	0.00586	CbGeAlD
Pimozide—CALM3—telencephalon—epilepsy syndrome	0.000253	0.00581	CbGeAlD
Pimozide—CHRM2—telencephalon—epilepsy syndrome	0.000249	0.00573	CbGeAlD
Pimozide—DRD3—central nervous system—epilepsy syndrome	0.000245	0.00564	CbGeAlD
Pimozide—HTR6—nervous system—epilepsy syndrome	0.000245	0.00564	CbGeAlD
Pimozide—OPRK1—head—epilepsy syndrome	0.000239	0.00551	CbGeAlD
Pimozide—HTR2A—hindbrain—epilepsy syndrome	0.000237	0.00544	CbGeAlD
Pimozide—HTR6—central nervous system—epilepsy syndrome	0.000236	0.00543	CbGeAlD
Pimozide—HTR1A—brainstem—epilepsy syndrome	0.000228	0.00523	CbGeAlD
Pimozide—OPRK1—nervous system—epilepsy syndrome	0.000227	0.00522	CbGeAlD
Pimozide—CALM2—brainstem—epilepsy syndrome	0.000224	0.00514	CbGeAlD
Pimozide—CALM1—brainstem—epilepsy syndrome	0.000223	0.00512	CbGeAlD
Pimozide—HTR1A—forebrain—epilepsy syndrome	0.00022	0.00505	CbGeAlD
Pimozide—OPRK1—central nervous system—epilepsy syndrome	0.000219	0.00503	CbGeAlD
Pimozide—CALM2—forebrain—epilepsy syndrome	0.000216	0.00496	CbGeAlD
Pimozide—CYP2D6—hindbrain—epilepsy syndrome	0.000216	0.00496	CbGeAlD
Pimozide—CALM1—forebrain—epilepsy syndrome	0.000215	0.00494	CbGeAlD
Pimozide—OPRK1—cerebellum—epilepsy syndrome	0.000214	0.00491	CbGeAlD
Pimozide—DRD2—brainstem—epilepsy syndrome	0.000206	0.00473	CbGeAlD
Pimozide—HTR1A—telencephalon—epilepsy syndrome	0.000202	0.00464	CbGeAlD
Pimozide—CALM3—medulla oblongata—epilepsy syndrome	0.000199	0.00457	CbGeAlD
Pimozide—CALM2—telencephalon—epilepsy syndrome	0.000199	0.00457	CbGeAlD
Pimozide—DRD2—forebrain—epilepsy syndrome	0.000198	0.00456	CbGeAlD
Pimozide—CALM1—telencephalon—epilepsy syndrome	0.000198	0.00454	CbGeAlD
Pimozide—OPRM1—midbrain—epilepsy syndrome	0.000196	0.00452	CbGeAlD
Pimozide—KCNH2—forebrain—epilepsy syndrome	0.000196	0.0045	CbGeAlD
Pimozide—DRD3—brain—epilepsy syndrome	0.000195	0.00448	CbGeAlD
Pimozide—OPRM1—spinal cord—epilepsy syndrome	0.000192	0.00441	CbGeAlD
Pimozide—HTR6—brain—epilepsy syndrome	0.000187	0.00431	CbGeAlD
Pimozide—DRD2—telencephalon—epilepsy syndrome	0.000183	0.0042	CbGeAlD
Pimozide—CALM3—midbrain—epilepsy syndrome	0.000182	0.00417	CbGeAlD
Pimozide—Ezetimibe—ABCC2—epilepsy syndrome	0.000181	0.0691	CrCbGaD
Pimozide—KCNH2—telencephalon—epilepsy syndrome	0.00018	0.00414	CbGeAlD
Pimozide—CALM3—spinal cord—epilepsy syndrome	0.000177	0.00407	CbGeAlD
Pimozide—OPRK1—brain—epilepsy syndrome	0.000174	0.00399	CbGeAlD
Pimozide—OPRM1—head—epilepsy syndrome	0.00017	0.00392	CbGeAlD
Pimozide—OPRM1—nervous system—epilepsy syndrome	0.000161	0.00371	CbGeAlD
Pimozide—Ezetimibe—ABCG2—epilepsy syndrome	0.00016	0.061	CrCbGaD
Pimozide—HRH1—forebrain—epilepsy syndrome	0.000157	0.0036	CbGeAlD
Pimozide—CALM2—medulla oblongata—epilepsy syndrome	0.000156	0.00359	CbGeAlD
Pimozide—OPRM1—central nervous system—epilepsy syndrome	0.000155	0.00358	CbGeAlD
Pimozide—Sertindole—ADRA2A—epilepsy syndrome	0.000155	0.0591	CrCbGaD
Pimozide—CALM1—medulla oblongata—epilepsy syndrome	0.000155	0.00357	CbGeAlD
Pimozide—CHRM2—head—epilepsy syndrome	0.000155	0.00357	CbGeAlD
Pimozide—CHRM2—nervous system—epilepsy syndrome	0.000147	0.00338	CbGeAlD
Pimozide—HTR1A—midbrain—epilepsy syndrome	0.000145	0.00334	CbGeAlD
Pimozide—HRH1—telencephalon—epilepsy syndrome	0.000144	0.00331	CbGeAlD
Pimozide—CALM2—midbrain—epilepsy syndrome	0.000143	0.00328	CbGeAlD
Pimozide—CALM1—midbrain—epilepsy syndrome	0.000142	0.00326	CbGeAlD
Pimozide—HTR1A—spinal cord—epilepsy syndrome	0.000142	0.00325	CbGeAlD
Pimozide—CHRM2—central nervous system—epilepsy syndrome	0.000142	0.00325	CbGeAlD
Pimozide—Droperidol—HTR2A—epilepsy syndrome	0.000141	0.0538	CrCbGaD
Pimozide—KCNH2—medulla oblongata—epilepsy syndrome	0.000141	0.00325	CbGeAlD
Pimozide—CALM3—cerebellum—epilepsy syndrome	0.00014	0.00323	CbGeAlD
Pimozide—CALM2—spinal cord—epilepsy syndrome	0.000139	0.0032	CbGeAlD
Pimozide—CYP2E1—telencephalon—epilepsy syndrome	0.000138	0.00318	CbGeAlD
Pimozide—CALM1—spinal cord—epilepsy syndrome	0.000138	0.00318	CbGeAlD
Pimozide—HTR2A—brainstem—epilepsy syndrome	0.000136	0.00312	CbGeAlD
Pimozide—DRD2—midbrain—epilepsy syndrome	0.000131	0.00301	CbGeAlD
Pimozide—HTR2A—forebrain—epilepsy syndrome	0.000131	0.00301	CbGeAlD
Pimozide—KCNH2—midbrain—epilepsy syndrome	0.000129	0.00297	CbGeAlD
Pimozide—Fluspirilene—ADRA2A—epilepsy syndrome	0.000127	0.0482	CrCbGaD
Pimozide—KCNH2—spinal cord—epilepsy syndrome	0.000126	0.0029	CbGeAlD
Pimozide—HTR1A—head—epilepsy syndrome	0.000126	0.00289	CbGeAlD
Pimozide—CALM2—head—epilepsy syndrome	0.000124	0.00284	CbGeAlD
Pimozide—CYP2D6—brainstem—epilepsy syndrome	0.000124	0.00284	CbGeAlD
Pimozide—OPRM1—brain—epilepsy syndrome	0.000123	0.00284	CbGeAlD
Pimozide—CALM1—head—epilepsy syndrome	0.000123	0.00283	CbGeAlD
Pimozide—HTR2A—telencephalon—epilepsy syndrome	0.00012	0.00277	CbGeAlD
Pimozide—CYP2D6—forebrain—epilepsy syndrome	0.000119	0.00274	CbGeAlD
Pimozide—HTR1A—nervous system—epilepsy syndrome	0.000119	0.00274	CbGeAlD
Pimozide—Sertindole—SLC6A4—epilepsy syndrome	0.000118	0.0451	CrCbGaD
Pimozide—CALM2—nervous system—epilepsy syndrome	0.000117	0.0027	CbGeAlD
Pimozide—CALM1—nervous system—epilepsy syndrome	0.000117	0.00268	CbGeAlD
Pimozide—HTR1A—central nervous system—epilepsy syndrome	0.000115	0.00264	CbGeAlD
Pimozide—CALM3—brain—epilepsy syndrome	0.000114	0.00262	CbGeAlD
Pimozide—DRD2—head—epilepsy syndrome	0.000114	0.00261	CbGeAlD
Pimozide—CALM2—central nervous system—epilepsy syndrome	0.000113	0.00259	CbGeAlD
Pimozide—CHRM2—brain—epilepsy syndrome	0.000112	0.00258	CbGeAlD
Pimozide—CALM1—central nervous system—epilepsy syndrome	0.000112	0.00258	CbGeAlD
Pimozide—HTR1A—cerebellum—epilepsy syndrome	0.000112	0.00258	CbGeAlD
Pimozide—KCNH2—head—epilepsy syndrome	0.000112	0.00258	CbGeAlD
Pimozide—CALM2—cerebellum—epilepsy syndrome	0.00011	0.00254	CbGeAlD
Pimozide—CALM1—cerebellum—epilepsy syndrome	0.00011	0.00252	CbGeAlD
Pimozide—CYP2D6—telencephalon—epilepsy syndrome	0.00011	0.00252	CbGeAlD
Pimozide—CYP2E1—medulla oblongata—epilepsy syndrome	0.000109	0.0025	CbGeAlD
Pimozide—DRD2—nervous system—epilepsy syndrome	0.000108	0.00248	CbGeAlD
Pimozide—KCNH2—nervous system—epilepsy syndrome	0.000106	0.00244	CbGeAlD
Pimozide—DRD2—central nervous system—epilepsy syndrome	0.000104	0.00239	CbGeAlD
Pimozide—KCNH2—central nervous system—epilepsy syndrome	0.000102	0.00235	CbGeAlD
Pimozide—DRD2—cerebellum—epilepsy syndrome	0.000101	0.00233	CbGeAlD
Pimozide—KCNH2—cerebellum—epilepsy syndrome	9.99e-05	0.0023	CbGeAlD
Pimozide—CYP2E1—spinal cord—epilepsy syndrome	9.7e-05	0.00223	CbGeAlD
Pimozide—Fluspirilene—SLC6A4—epilepsy syndrome	9.66e-05	0.0368	CrCbGaD
Pimozide—HTR2A—medulla oblongata—epilepsy syndrome	9.46e-05	0.00218	CbGeAlD
Pimozide—Astemizole—CYP2D6—epilepsy syndrome	9.34e-05	0.0356	CrCbGaD
Pimozide—HTR1A—brain—epilepsy syndrome	9.11e-05	0.0021	CbGeAlD
Pimozide—Sertindole—HTR2A—epilepsy syndrome	9.11e-05	0.0347	CrCbGaD
Pimozide—HRH1—head—epilepsy syndrome	8.97e-05	0.00206	CbGeAlD
Pimozide—CALM2—brain—epilepsy syndrome	8.96e-05	0.00206	CbGeAlD
Pimozide—CALM1—brain—epilepsy syndrome	8.92e-05	0.00205	CbGeAlD
Pimozide—HTR2A—midbrain—epilepsy syndrome	8.64e-05	0.00199	CbGeAlD
Pimozide—CYP2E1—head—epilepsy syndrome	8.62e-05	0.00198	CbGeAlD
Pimozide—ABCB1—forebrain—epilepsy syndrome	8.58e-05	0.00197	CbGeAlD
Pimozide—HRH1—nervous system—epilepsy syndrome	8.51e-05	0.00196	CbGeAlD
Pimozide—HTR2A—spinal cord—epilepsy syndrome	8.43e-05	0.00194	CbGeAlD
Pimozide—Sertindole—CYP2D6—epilepsy syndrome	8.33e-05	0.0317	CrCbGaD
Pimozide—DRD2—brain—epilepsy syndrome	8.24e-05	0.00189	CbGeAlD
Pimozide—HRH1—central nervous system—epilepsy syndrome	8.19e-05	0.00188	CbGeAlD
Pimozide—CYP2E1—nervous system—epilepsy syndrome	8.18e-05	0.00188	CbGeAlD
Pimozide—KCNH2—brain—epilepsy syndrome	8.11e-05	0.00187	CbGeAlD
Pimozide—ABCB1—telencephalon—epilepsy syndrome	7.89e-05	0.00181	CbGeAlD
Pimozide—CYP2E1—central nervous system—epilepsy syndrome	7.87e-05	0.00181	CbGeAlD
Pimozide—CYP2E1—cerebellum—epilepsy syndrome	7.69e-05	0.00177	CbGeAlD
Pimozide—HTR2A—head—epilepsy syndrome	7.5e-05	0.00172	CbGeAlD
Pimozide—Fluspirilene—HTR2A—epilepsy syndrome	7.42e-05	0.0283	CrCbGaD
Pimozide—HTR2A—nervous system—epilepsy syndrome	7.11e-05	0.00163	CbGeAlD
Pimozide—HTR2A—central nervous system—epilepsy syndrome	6.84e-05	0.00157	CbGeAlD
Pimozide—CYP2D6—head—epilepsy syndrome	6.83e-05	0.00157	CbGeAlD
Pimozide—HTR2A—cerebellum—epilepsy syndrome	6.69e-05	0.00154	CbGeAlD
Pimozide—Astemizole—ABCB1—epilepsy syndrome	6.67e-05	0.0254	CrCbGaD
Pimozide—Ezetimibe—ABCB1—epilepsy syndrome	6.67e-05	0.0254	CrCbGaD
Pimozide—Fexofenadine—CYP2D6—epilepsy syndrome	6.66e-05	0.0254	CrCbGaD
Pimozide—CYP3A4—nervous system—epilepsy syndrome	6.58e-05	0.00151	CbGeAlD
Pimozide—HRH1—brain—epilepsy syndrome	6.5e-05	0.0015	CbGeAlD
Pimozide—CYP2D6—nervous system—epilepsy syndrome	6.47e-05	0.00149	CbGeAlD
Pimozide—CYP3A4—central nervous system—epilepsy syndrome	6.33e-05	0.00146	CbGeAlD
Pimozide—CYP2E1—brain—epilepsy syndrome	6.25e-05	0.00144	CbGeAlD
Pimozide—CYP2D6—central nervous system—epilepsy syndrome	6.23e-05	0.00143	CbGeAlD
Pimozide—ABCB1—medulla oblongata—epilepsy syndrome	6.2e-05	0.00143	CbGeAlD
Pimozide—CYP2D6—cerebellum—epilepsy syndrome	6.09e-05	0.0014	CbGeAlD
Pimozide—Domperidone—CYP2D6—epilepsy syndrome	6.08e-05	0.0231	CrCbGaD
Pimozide—ABCB1—midbrain—epilepsy syndrome	5.66e-05	0.0013	CbGeAlD
Pimozide—ABCB1—spinal cord—epilepsy syndrome	5.53e-05	0.00127	CbGeAlD
Pimozide—Flunarizine—CYP2D6—epilepsy syndrome	5.5e-05	0.021	CrCbGaD
Pimozide—HTR2A—brain—epilepsy syndrome	5.43e-05	0.00125	CbGeAlD
Pimozide—CYP2D6—brain—epilepsy syndrome	4.95e-05	0.00114	CbGeAlD
Pimozide—ABCB1—head—epilepsy syndrome	4.91e-05	0.00113	CbGeAlD
Pimozide—Fexofenadine—ABCB1—epilepsy syndrome	4.75e-05	0.0181	CrCbGaD
Pimozide—ABCB1—nervous system—epilepsy syndrome	4.66e-05	0.00107	CbGeAlD
Pimozide—ABCB1—central nervous system—epilepsy syndrome	4.48e-05	0.00103	CbGeAlD
Pimozide—ABCB1—cerebellum—epilepsy syndrome	4.38e-05	0.00101	CbGeAlD
Pimozide—Diarrhoea—Fosphenytoin—epilepsy syndrome	4.35e-05	0.000346	CcSEcCtD
Pimozide—Domperidone—ABCB1—epilepsy syndrome	4.34e-05	0.0165	CrCbGaD
Pimozide—Vomiting—Propofol—epilepsy syndrome	4.34e-05	0.000345	CcSEcCtD
Pimozide—Muscle spasms—Pregabalin—epilepsy syndrome	4.32e-05	0.000344	CcSEcCtD
Pimozide—Pruritus—Diazepam—epilepsy syndrome	4.32e-05	0.000343	CcSEcCtD
Pimozide—Rash—Propofol—epilepsy syndrome	4.3e-05	0.000342	CcSEcCtD
Pimozide—Dermatitis—Propofol—epilepsy syndrome	4.3e-05	0.000342	CcSEcCtD
Pimozide—Hypertension—Valproic Acid—epilepsy syndrome	4.29e-05	0.000341	CcSEcCtD
Pimozide—Headache—Propofol—epilepsy syndrome	4.27e-05	0.00034	CcSEcCtD
Pimozide—Vomiting—Midazolam—epilepsy syndrome	4.24e-05	0.000337	CcSEcCtD
Pimozide—Diarrhoea—Vigabatrin—epilepsy syndrome	4.24e-05	0.000337	CcSEcCtD
Pimozide—Asthenia—Felbamate—epilepsy syndrome	4.24e-05	0.000337	CcSEcCtD
Pimozide—Vision blurred—Pregabalin—epilepsy syndrome	4.24e-05	0.000337	CcSEcCtD
Pimozide—Myalgia—Valproic Acid—epilepsy syndrome	4.23e-05	0.000337	CcSEcCtD
Pimozide—Chest pain—Valproic Acid—epilepsy syndrome	4.23e-05	0.000337	CcSEcCtD
Pimozide—Tremor—Pregabalin—epilepsy syndrome	4.21e-05	0.000335	CcSEcCtD
Pimozide—Rash—Midazolam—epilepsy syndrome	4.21e-05	0.000335	CcSEcCtD
Pimozide—Dizziness—Fosphenytoin—epilepsy syndrome	4.21e-05	0.000334	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	4.2e-05	0.000334	CcSEcCtD
Pimozide—Dermatitis—Midazolam—epilepsy syndrome	4.2e-05	0.000334	CcSEcCtD
Pimozide—Urticaria—Carbamazepine—epilepsy syndrome	4.2e-05	0.000334	CcSEcCtD
Pimozide—Vomiting—Levetiracetam—epilepsy syndrome	4.19e-05	0.000333	CcSEcCtD
Pimozide—Headache—Midazolam—epilepsy syndrome	4.18e-05	0.000332	CcSEcCtD
Pimozide—Pruritus—Felbamate—epilepsy syndrome	4.18e-05	0.000332	CcSEcCtD
Pimozide—Diarrhoea—Diazepam—epilepsy syndrome	4.18e-05	0.000332	CcSEcCtD
Pimozide—Rash—Levetiracetam—epilepsy syndrome	4.16e-05	0.00033	CcSEcCtD
Pimozide—Anaemia—Pregabalin—epilepsy syndrome	4.15e-05	0.00033	CcSEcCtD
Pimozide—Dermatitis—Levetiracetam—epilepsy syndrome	4.15e-05	0.00033	CcSEcCtD
Pimozide—Asthenia—Zonisamide—epilepsy syndrome	4.15e-05	0.00033	CcSEcCtD
Pimozide—Mental disorder—Gabapentin—epilepsy syndrome	4.15e-05	0.00033	CcSEcCtD
Pimozide—Agranulocytosis—Topiramate—epilepsy syndrome	4.14e-05	0.000329	CcSEcCtD
Pimozide—Dry mouth—Valproic Acid—epilepsy syndrome	4.14e-05	0.000329	CcSEcCtD
Pimozide—Agitation—Pregabalin—epilepsy syndrome	4.13e-05	0.000329	CcSEcCtD
Pimozide—Headache—Levetiracetam—epilepsy syndrome	4.13e-05	0.000328	CcSEcCtD
Pimozide—Dizziness—Vigabatrin—epilepsy syndrome	4.1e-05	0.000326	CcSEcCtD
Pimozide—Pruritus—Zonisamide—epilepsy syndrome	4.09e-05	0.000325	CcSEcCtD
Pimozide—Urticaria—Lamotrigine—epilepsy syndrome	4.06e-05	0.000323	CcSEcCtD
Pimozide—Nausea—Propofol—epilepsy syndrome	4.05e-05	0.000322	CcSEcCtD
Pimozide—Vomiting—Fosphenytoin—epilepsy syndrome	4.04e-05	0.000322	CcSEcCtD
Pimozide—Diarrhoea—Felbamate—epilepsy syndrome	4.04e-05	0.000321	CcSEcCtD
Pimozide—Dizziness—Diazepam—epilepsy syndrome	4.04e-05	0.000321	CcSEcCtD
Pimozide—Syncope—Pregabalin—epilepsy syndrome	4.03e-05	0.000321	CcSEcCtD
Pimozide—Leukopenia—Pregabalin—epilepsy syndrome	4.02e-05	0.00032	CcSEcCtD
Pimozide—Rash—Fosphenytoin—epilepsy syndrome	4.01e-05	0.000319	CcSEcCtD
Pimozide—Dermatitis—Fosphenytoin—epilepsy syndrome	4.01e-05	0.000319	CcSEcCtD
Pimozide—Asthenia—Clonazepam—epilepsy syndrome	4e-05	0.000318	CcSEcCtD
Pimozide—Headache—Fosphenytoin—epilepsy syndrome	3.98e-05	0.000317	CcSEcCtD
Pimozide—Nervous system disorder—Valproic Acid—epilepsy syndrome	3.98e-05	0.000316	CcSEcCtD
Pimozide—Palpitations—Pregabalin—epilepsy syndrome	3.97e-05	0.000316	CcSEcCtD
Pimozide—Asthenia—Phenytoin—epilepsy syndrome	3.97e-05	0.000316	CcSEcCtD
Pimozide—Nausea—Midazolam—epilepsy syndrome	3.96e-05	0.000315	CcSEcCtD
Pimozide—Muscle spasms—Gabapentin—epilepsy syndrome	3.96e-05	0.000315	CcSEcCtD
Pimozide—Tachycardia—Valproic Acid—epilepsy syndrome	3.96e-05	0.000315	CcSEcCtD
Pimozide—Diarrhoea—Zonisamide—epilepsy syndrome	3.96e-05	0.000315	CcSEcCtD
Pimozide—Loss of consciousness—Pregabalin—epilepsy syndrome	3.95e-05	0.000314	CcSEcCtD
Pimozide—Asthenia—Oxcarbazepine—epilepsy syndrome	3.95e-05	0.000314	CcSEcCtD
Pimozide—Pruritus—Clonazepam—epilepsy syndrome	3.94e-05	0.000314	CcSEcCtD
Pimozide—Vomiting—Vigabatrin—epilepsy syndrome	3.94e-05	0.000313	CcSEcCtD
Pimozide—Skin disorder—Valproic Acid—epilepsy syndrome	3.94e-05	0.000313	CcSEcCtD
Pimozide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	3.92e-05	0.000312	CcSEcCtD
Pimozide—Pruritus—Phenytoin—epilepsy syndrome	3.92e-05	0.000311	CcSEcCtD
Pimozide—Connective tissue disorder—Topiramate—epilepsy syndrome	3.91e-05	0.000311	CcSEcCtD
Pimozide—Nausea—Levetiracetam—epilepsy syndrome	3.91e-05	0.000311	CcSEcCtD
Pimozide—Rash—Vigabatrin—epilepsy syndrome	3.91e-05	0.000311	CcSEcCtD
Pimozide—Dizziness—Felbamate—epilepsy syndrome	3.91e-05	0.000311	CcSEcCtD
Pimozide—Dermatitis—Vigabatrin—epilepsy syndrome	3.91e-05	0.000311	CcSEcCtD
Pimozide—Pruritus—Oxcarbazepine—epilepsy syndrome	3.9e-05	0.00031	CcSEcCtD
Pimozide—Convulsion—Pregabalin—epilepsy syndrome	3.89e-05	0.00031	CcSEcCtD
Pimozide—Vision blurred—Gabapentin—epilepsy syndrome	3.88e-05	0.000309	CcSEcCtD
Pimozide—Headache—Vigabatrin—epilepsy syndrome	3.88e-05	0.000309	CcSEcCtD
Pimozide—Hypertension—Pregabalin—epilepsy syndrome	3.88e-05	0.000309	CcSEcCtD
Pimozide—Vomiting—Diazepam—epilepsy syndrome	3.88e-05	0.000309	CcSEcCtD
Pimozide—Anorexia—Valproic Acid—epilepsy syndrome	3.87e-05	0.000308	CcSEcCtD
Pimozide—Tremor—Gabapentin—epilepsy syndrome	3.86e-05	0.000307	CcSEcCtD
Pimozide—Rash—Diazepam—epilepsy syndrome	3.85e-05	0.000306	CcSEcCtD
Pimozide—Dermatitis—Diazepam—epilepsy syndrome	3.84e-05	0.000306	CcSEcCtD
Pimozide—Visual impairment—Topiramate—epilepsy syndrome	3.84e-05	0.000305	CcSEcCtD
Pimozide—Myalgia—Pregabalin—epilepsy syndrome	3.83e-05	0.000304	CcSEcCtD
Pimozide—Chest pain—Pregabalin—epilepsy syndrome	3.83e-05	0.000304	CcSEcCtD
Pimozide—Dizziness—Zonisamide—epilepsy syndrome	3.82e-05	0.000304	CcSEcCtD
Pimozide—Headache—Diazepam—epilepsy syndrome	3.82e-05	0.000304	CcSEcCtD
Pimozide—Diarrhoea—Clonazepam—epilepsy syndrome	3.81e-05	0.000303	CcSEcCtD
Pimozide—Anaemia—Gabapentin—epilepsy syndrome	3.81e-05	0.000303	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.8e-05	0.000302	CcSEcCtD
Pimozide—Hypotension—Valproic Acid—epilepsy syndrome	3.79e-05	0.000302	CcSEcCtD
Pimozide—Asthenia—Carbamazepine—epilepsy syndrome	3.79e-05	0.000301	CcSEcCtD
Pimozide—Agitation—Gabapentin—epilepsy syndrome	3.79e-05	0.000301	CcSEcCtD
Pimozide—Diarrhoea—Phenytoin—epilepsy syndrome	3.79e-05	0.000301	CcSEcCtD
Pimozide—Nausea—Fosphenytoin—epilepsy syndrome	3.78e-05	0.0003	CcSEcCtD
Pimozide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.77e-05	0.0003	CcSEcCtD
Pimozide—Vomiting—Felbamate—epilepsy syndrome	3.76e-05	0.000299	CcSEcCtD
Pimozide—Dry mouth—Pregabalin—epilepsy syndrome	3.74e-05	0.000298	CcSEcCtD
Pimozide—Pruritus—Carbamazepine—epilepsy syndrome	3.74e-05	0.000297	CcSEcCtD
Pimozide—Rash—Felbamate—epilepsy syndrome	3.72e-05	0.000296	CcSEcCtD
Pimozide—Eye disorder—Topiramate—epilepsy syndrome	3.72e-05	0.000296	CcSEcCtD
Pimozide—Dermatitis—Felbamate—epilepsy syndrome	3.72e-05	0.000296	CcSEcCtD
Pimozide—Headache—Felbamate—epilepsy syndrome	3.7e-05	0.000294	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.7e-05	0.000294	CcSEcCtD
Pimozide—Cardiac disorder—Topiramate—epilepsy syndrome	3.7e-05	0.000294	CcSEcCtD
Pimozide—Syncope—Gabapentin—epilepsy syndrome	3.7e-05	0.000294	CcSEcCtD
Pimozide—Leukopenia—Gabapentin—epilepsy syndrome	3.69e-05	0.000293	CcSEcCtD
Pimozide—Dizziness—Clonazepam—epilepsy syndrome	3.69e-05	0.000293	CcSEcCtD
Pimozide—Nausea—Vigabatrin—epilepsy syndrome	3.68e-05	0.000293	CcSEcCtD
Pimozide—Vomiting—Zonisamide—epilepsy syndrome	3.68e-05	0.000292	CcSEcCtD
Pimozide—Insomnia—Valproic Acid—epilepsy syndrome	3.67e-05	0.000292	CcSEcCtD
Pimozide—Asthenia—Lamotrigine—epilepsy syndrome	3.66e-05	0.000291	CcSEcCtD
Pimozide—Dizziness—Phenytoin—epilepsy syndrome	3.66e-05	0.000291	CcSEcCtD
Pimozide—Rash—Zonisamide—epilepsy syndrome	3.65e-05	0.00029	CcSEcCtD
Pimozide—Palpitations—Gabapentin—epilepsy syndrome	3.64e-05	0.00029	CcSEcCtD
Pimozide—Dermatitis—Zonisamide—epilepsy syndrome	3.64e-05	0.00029	CcSEcCtD
Pimozide—Dizziness—Oxcarbazepine—epilepsy syndrome	3.64e-05	0.00029	CcSEcCtD
Pimozide—Nausea—Diazepam—epilepsy syndrome	3.63e-05	0.000288	CcSEcCtD
Pimozide—Loss of consciousness—Gabapentin—epilepsy syndrome	3.62e-05	0.000288	CcSEcCtD
Pimozide—Headache—Zonisamide—epilepsy syndrome	3.62e-05	0.000288	CcSEcCtD
Pimozide—Diarrhoea—Carbamazepine—epilepsy syndrome	3.62e-05	0.000288	CcSEcCtD
Pimozide—Pruritus—Lamotrigine—epilepsy syndrome	3.61e-05	0.000287	CcSEcCtD
Pimozide—Shock—Pregabalin—epilepsy syndrome	3.61e-05	0.000287	CcSEcCtD
Pimozide—Somnolence—Valproic Acid—epilepsy syndrome	3.61e-05	0.000287	CcSEcCtD
Pimozide—Nervous system disorder—Pregabalin—epilepsy syndrome	3.6e-05	0.000286	CcSEcCtD
Pimozide—Tachycardia—Pregabalin—epilepsy syndrome	3.58e-05	0.000285	CcSEcCtD
Pimozide—Convulsion—Gabapentin—epilepsy syndrome	3.57e-05	0.000284	CcSEcCtD
Pimozide—Skin disorder—Pregabalin—epilepsy syndrome	3.56e-05	0.000283	CcSEcCtD
Pimozide—ABCB1—brain—epilepsy syndrome	3.56e-05	0.000819	CbGeAlD
Pimozide—Hypertension—Gabapentin—epilepsy syndrome	3.56e-05	0.000283	CcSEcCtD
Pimozide—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.55e-05	0.000282	CcSEcCtD
Pimozide—Vomiting—Clonazepam—epilepsy syndrome	3.54e-05	0.000282	CcSEcCtD
Pimozide—Decreased appetite—Valproic Acid—epilepsy syndrome	3.53e-05	0.000281	CcSEcCtD
Pimozide—Vomiting—Phenytoin—epilepsy syndrome	3.52e-05	0.00028	CcSEcCtD
Pimozide—Rash—Clonazepam—epilepsy syndrome	3.51e-05	0.000279	CcSEcCtD
Pimozide—Dermatitis—Clonazepam—epilepsy syndrome	3.51e-05	0.000279	CcSEcCtD
Pimozide—Myalgia—Gabapentin—epilepsy syndrome	3.51e-05	0.000279	CcSEcCtD
Pimozide—Chest pain—Gabapentin—epilepsy syndrome	3.51e-05	0.000279	CcSEcCtD
Pimozide—Nausea—Felbamate—epilepsy syndrome	3.51e-05	0.000279	CcSEcCtD
Pimozide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.5e-05	0.000279	CcSEcCtD
Pimozide—Vomiting—Oxcarbazepine—epilepsy syndrome	3.5e-05	0.000278	CcSEcCtD
Pimozide—Anorexia—Pregabalin—epilepsy syndrome	3.5e-05	0.000278	CcSEcCtD
Pimozide—Dizziness—Carbamazepine—epilepsy syndrome	3.49e-05	0.000278	CcSEcCtD
Pimozide—Diarrhoea—Lamotrigine—epilepsy syndrome	3.49e-05	0.000278	CcSEcCtD
Pimozide—Headache—Clonazepam—epilepsy syndrome	3.49e-05	0.000278	CcSEcCtD
Pimozide—Rash—Phenytoin—epilepsy syndrome	3.49e-05	0.000278	CcSEcCtD
Pimozide—Mental disorder—Topiramate—epilepsy syndrome	3.49e-05	0.000278	CcSEcCtD
Pimozide—Dermatitis—Phenytoin—epilepsy syndrome	3.49e-05	0.000277	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.49e-05	0.000277	CcSEcCtD
Pimozide—Rash—Oxcarbazepine—epilepsy syndrome	3.47e-05	0.000276	CcSEcCtD
Pimozide—Constipation—Valproic Acid—epilepsy syndrome	3.47e-05	0.000276	CcSEcCtD
Pimozide—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.47e-05	0.000276	CcSEcCtD
Pimozide—Headache—Phenytoin—epilepsy syndrome	3.47e-05	0.000276	CcSEcCtD
Pimozide—Headache—Oxcarbazepine—epilepsy syndrome	3.45e-05	0.000274	CcSEcCtD
Pimozide—Nausea—Zonisamide—epilepsy syndrome	3.43e-05	0.000273	CcSEcCtD
Pimozide—Dry mouth—Gabapentin—epilepsy syndrome	3.43e-05	0.000273	CcSEcCtD
Pimozide—Hypotension—Pregabalin—epilepsy syndrome	3.43e-05	0.000273	CcSEcCtD
Pimozide—Dizziness—Lamotrigine—epilepsy syndrome	3.38e-05	0.000269	CcSEcCtD
Pimozide—Vomiting—Carbamazepine—epilepsy syndrome	3.36e-05	0.000267	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.34e-05	0.000266	CcSEcCtD
Pimozide—Muscle spasms—Topiramate—epilepsy syndrome	3.33e-05	0.000265	CcSEcCtD
Pimozide—Rash—Carbamazepine—epilepsy syndrome	3.33e-05	0.000265	CcSEcCtD
Pimozide—Dermatitis—Carbamazepine—epilepsy syndrome	3.33e-05	0.000265	CcSEcCtD
Pimozide—Insomnia—Pregabalin—epilepsy syndrome	3.32e-05	0.000264	CcSEcCtD
Pimozide—Nausea—Clonazepam—epilepsy syndrome	3.31e-05	0.000263	CcSEcCtD
Pimozide—Headache—Carbamazepine—epilepsy syndrome	3.31e-05	0.000263	CcSEcCtD
Pimozide—Shock—Gabapentin—epilepsy syndrome	3.31e-05	0.000263	CcSEcCtD
Pimozide—Nervous system disorder—Gabapentin—epilepsy syndrome	3.3e-05	0.000262	CcSEcCtD
Pimozide—Nausea—Phenytoin—epilepsy syndrome	3.29e-05	0.000261	CcSEcCtD
Pimozide—Tachycardia—Gabapentin—epilepsy syndrome	3.28e-05	0.000261	CcSEcCtD
Pimozide—Nausea—Oxcarbazepine—epilepsy syndrome	3.27e-05	0.00026	CcSEcCtD
Pimozide—Vision blurred—Topiramate—epilepsy syndrome	3.27e-05	0.00026	CcSEcCtD
Pimozide—Skin disorder—Gabapentin—epilepsy syndrome	3.27e-05	0.00026	CcSEcCtD
Pimozide—Somnolence—Pregabalin—epilepsy syndrome	3.26e-05	0.000259	CcSEcCtD
Pimozide—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.25e-05	0.000259	CcSEcCtD
Pimozide—Tremor—Topiramate—epilepsy syndrome	3.25e-05	0.000258	CcSEcCtD
Pimozide—Vomiting—Lamotrigine—epilepsy syndrome	3.25e-05	0.000258	CcSEcCtD
Pimozide—Urticaria—Valproic Acid—epilepsy syndrome	3.22e-05	0.000256	CcSEcCtD
Pimozide—Rash—Lamotrigine—epilepsy syndrome	3.22e-05	0.000256	CcSEcCtD
Pimozide—Dermatitis—Lamotrigine—epilepsy syndrome	3.22e-05	0.000256	CcSEcCtD
Pimozide—Anorexia—Gabapentin—epilepsy syndrome	3.21e-05	0.000255	CcSEcCtD
Pimozide—Anaemia—Topiramate—epilepsy syndrome	3.21e-05	0.000255	CcSEcCtD
Pimozide—Headache—Lamotrigine—epilepsy syndrome	3.2e-05	0.000254	CcSEcCtD
Pimozide—Decreased appetite—Pregabalin—epilepsy syndrome	3.19e-05	0.000254	CcSEcCtD
Pimozide—Agitation—Topiramate—epilepsy syndrome	3.19e-05	0.000253	CcSEcCtD
Pimozide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.17e-05	0.000252	CcSEcCtD
Pimozide—Hypotension—Gabapentin—epilepsy syndrome	3.14e-05	0.00025	CcSEcCtD
Pimozide—Nausea—Carbamazepine—epilepsy syndrome	3.14e-05	0.00025	CcSEcCtD
Pimozide—Constipation—Pregabalin—epilepsy syndrome	3.14e-05	0.000249	CcSEcCtD
Pimozide—Syncope—Topiramate—epilepsy syndrome	3.11e-05	0.000247	CcSEcCtD
Pimozide—Leukopenia—Topiramate—epilepsy syndrome	3.1e-05	0.000247	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.07e-05	0.000244	CcSEcCtD
Pimozide—Palpitations—Topiramate—epilepsy syndrome	3.06e-05	0.000244	CcSEcCtD
Pimozide—Loss of consciousness—Topiramate—epilepsy syndrome	3.05e-05	0.000242	CcSEcCtD
Pimozide—Insomnia—Gabapentin—epilepsy syndrome	3.04e-05	0.000242	CcSEcCtD
Pimozide—Nausea—Lamotrigine—epilepsy syndrome	3.03e-05	0.000241	CcSEcCtD
Pimozide—Convulsion—Topiramate—epilepsy syndrome	3e-05	0.000239	CcSEcCtD
Pimozide—Hypertension—Topiramate—epilepsy syndrome	2.99e-05	0.000238	CcSEcCtD
Pimozide—Somnolence—Gabapentin—epilepsy syndrome	2.99e-05	0.000238	CcSEcCtD
Pimozide—Myalgia—Topiramate—epilepsy syndrome	2.95e-05	0.000235	CcSEcCtD
Pimozide—Chest pain—Topiramate—epilepsy syndrome	2.95e-05	0.000235	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.93e-05	0.000233	CcSEcCtD
Pimozide—Decreased appetite—Gabapentin—epilepsy syndrome	2.92e-05	0.000233	CcSEcCtD
Pimozide—Urticaria—Pregabalin—epilepsy syndrome	2.91e-05	0.000232	CcSEcCtD
Pimozide—Asthenia—Valproic Acid—epilepsy syndrome	2.91e-05	0.000232	CcSEcCtD
Pimozide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.9e-05	0.000231	CcSEcCtD
Pimozide—Dry mouth—Topiramate—epilepsy syndrome	2.89e-05	0.00023	CcSEcCtD
Pimozide—Constipation—Gabapentin—epilepsy syndrome	2.88e-05	0.000229	CcSEcCtD
Pimozide—Pruritus—Valproic Acid—epilepsy syndrome	2.87e-05	0.000228	CcSEcCtD
Pimozide—Shock—Topiramate—epilepsy syndrome	2.78e-05	0.000221	CcSEcCtD
Pimozide—Diarrhoea—Valproic Acid—epilepsy syndrome	2.78e-05	0.000221	CcSEcCtD
Pimozide—Nervous system disorder—Topiramate—epilepsy syndrome	2.78e-05	0.000221	CcSEcCtD
Pimozide—Tachycardia—Topiramate—epilepsy syndrome	2.76e-05	0.00022	CcSEcCtD
Pimozide—Skin disorder—Topiramate—epilepsy syndrome	2.75e-05	0.000219	CcSEcCtD
Pimozide—Hyperhidrosis—Topiramate—epilepsy syndrome	2.74e-05	0.000218	CcSEcCtD
Pimozide—Anorexia—Topiramate—epilepsy syndrome	2.7e-05	0.000215	CcSEcCtD
Pimozide—Dizziness—Valproic Acid—epilepsy syndrome	2.68e-05	0.000213	CcSEcCtD
Pimozide—Urticaria—Gabapentin—epilepsy syndrome	2.67e-05	0.000213	CcSEcCtD
Pimozide—Hypotension—Topiramate—epilepsy syndrome	2.64e-05	0.00021	CcSEcCtD
Pimozide—Asthenia—Pregabalin—epilepsy syndrome	2.63e-05	0.000209	CcSEcCtD
Pimozide—Pruritus—Pregabalin—epilepsy syndrome	2.6e-05	0.000206	CcSEcCtD
Pimozide—Vomiting—Valproic Acid—epilepsy syndrome	2.58e-05	0.000205	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.58e-05	0.000205	CcSEcCtD
Pimozide—Insomnia—Topiramate—epilepsy syndrome	2.56e-05	0.000204	CcSEcCtD
Pimozide—Rash—Valproic Acid—epilepsy syndrome	2.56e-05	0.000203	CcSEcCtD
Pimozide—Dermatitis—Valproic Acid—epilepsy syndrome	2.56e-05	0.000203	CcSEcCtD
Pimozide—Headache—Valproic Acid—epilepsy syndrome	2.54e-05	0.000202	CcSEcCtD
Pimozide—Somnolence—Topiramate—epilepsy syndrome	2.52e-05	0.0002	CcSEcCtD
Pimozide—Diarrhoea—Pregabalin—epilepsy syndrome	2.51e-05	0.0002	CcSEcCtD
Pimozide—Decreased appetite—Topiramate—epilepsy syndrome	2.46e-05	0.000196	CcSEcCtD
Pimozide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.44e-05	0.000194	CcSEcCtD
Pimozide—Dizziness—Pregabalin—epilepsy syndrome	2.43e-05	0.000193	CcSEcCtD
Pimozide—Constipation—Topiramate—epilepsy syndrome	2.42e-05	0.000192	CcSEcCtD
Pimozide—Asthenia—Gabapentin—epilepsy syndrome	2.41e-05	0.000192	CcSEcCtD
Pimozide—Nausea—Valproic Acid—epilepsy syndrome	2.41e-05	0.000192	CcSEcCtD
Pimozide—Pruritus—Gabapentin—epilepsy syndrome	2.38e-05	0.000189	CcSEcCtD
Pimozide—Vomiting—Pregabalin—epilepsy syndrome	2.33e-05	0.000186	CcSEcCtD
Pimozide—Rash—Pregabalin—epilepsy syndrome	2.31e-05	0.000184	CcSEcCtD
Pimozide—Dermatitis—Pregabalin—epilepsy syndrome	2.31e-05	0.000184	CcSEcCtD
Pimozide—Diarrhoea—Gabapentin—epilepsy syndrome	2.3e-05	0.000183	CcSEcCtD
Pimozide—Headache—Pregabalin—epilepsy syndrome	2.3e-05	0.000183	CcSEcCtD
Pimozide—Urticaria—Topiramate—epilepsy syndrome	2.25e-05	0.000179	CcSEcCtD
Pimozide—Dizziness—Gabapentin—epilepsy syndrome	2.22e-05	0.000177	CcSEcCtD
Pimozide—Nausea—Pregabalin—epilepsy syndrome	2.18e-05	0.000173	CcSEcCtD
Pimozide—Vomiting—Gabapentin—epilepsy syndrome	2.14e-05	0.00017	CcSEcCtD
Pimozide—Rash—Gabapentin—epilepsy syndrome	2.12e-05	0.000169	CcSEcCtD
Pimozide—Dermatitis—Gabapentin—epilepsy syndrome	2.12e-05	0.000169	CcSEcCtD
Pimozide—Headache—Gabapentin—epilepsy syndrome	2.11e-05	0.000168	CcSEcCtD
Pimozide—Asthenia—Topiramate—epilepsy syndrome	2.03e-05	0.000161	CcSEcCtD
Pimozide—Pruritus—Topiramate—epilepsy syndrome	2e-05	0.000159	CcSEcCtD
Pimozide—Nausea—Gabapentin—epilepsy syndrome	2e-05	0.000159	CcSEcCtD
Pimozide—Diarrhoea—Topiramate—epilepsy syndrome	1.94e-05	0.000154	CcSEcCtD
Pimozide—Dizziness—Topiramate—epilepsy syndrome	1.87e-05	0.000149	CcSEcCtD
Pimozide—Vomiting—Topiramate—epilepsy syndrome	1.8e-05	0.000143	CcSEcCtD
Pimozide—Rash—Topiramate—epilepsy syndrome	1.78e-05	0.000142	CcSEcCtD
Pimozide—Dermatitis—Topiramate—epilepsy syndrome	1.78e-05	0.000142	CcSEcCtD
Pimozide—Headache—Topiramate—epilepsy syndrome	1.77e-05	0.000141	CcSEcCtD
Pimozide—Nausea—Topiramate—epilepsy syndrome	1.68e-05	0.000134	CcSEcCtD
Pimozide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	8.55e-07	9.67e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCR5—epilepsy syndrome	8.51e-07	9.61e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCR5—epilepsy syndrome	8.51e-07	9.61e-06	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	8.47e-07	9.58e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	8.47e-07	9.58e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—RELA—epilepsy syndrome	8.44e-07	9.54e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—RELA—epilepsy syndrome	8.44e-07	9.54e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—GPX1—epilepsy syndrome	8.44e-07	9.54e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—POMC—epilepsy syndrome	8.41e-07	9.51e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—FGF2—epilepsy syndrome	8.39e-07	9.49e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—FGF2—epilepsy syndrome	8.39e-07	9.49e-06	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—SRC—epilepsy syndrome	8.35e-07	9.44e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HTR2A—epilepsy syndrome	8.32e-07	9.41e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HTR2A—epilepsy syndrome	8.32e-07	9.41e-06	CbGpPWpGaD
Pimozide—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	8.3e-07	9.38e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	8.28e-07	9.36e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—MTOR—epilepsy syndrome	8.28e-07	9.36e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—MTOR—epilepsy syndrome	8.28e-07	9.36e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—POMC—epilepsy syndrome	8.27e-07	9.35e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—POMC—epilepsy syndrome	8.26e-07	9.34e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—POMC—epilepsy syndrome	8.25e-07	9.33e-06	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	8.25e-07	9.33e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	8.23e-07	9.31e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	8.22e-07	9.29e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—POMC—epilepsy syndrome	8.22e-07	9.29e-06	CbGpPWpGaD
Pimozide—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	8.22e-07	9.29e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TSC2—epilepsy syndrome	8.17e-07	9.24e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AGT—epilepsy syndrome	8.16e-07	9.23e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	8.14e-07	9.2e-06	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	8.13e-07	9.19e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	8.13e-07	9.19e-06	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—AKT1—epilepsy syndrome	8.13e-07	9.19e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	8.1e-07	9.16e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	8.08e-07	9.14e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—APOE—epilepsy syndrome	8e-07	9.04e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	7.98e-07	9.02e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	7.95e-07	8.99e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	7.95e-07	8.99e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—POMC—epilepsy syndrome	7.95e-07	8.99e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—POMC—epilepsy syndrome	7.95e-07	8.99e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TSC2—epilepsy syndrome	7.91e-07	8.94e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TSC2—epilepsy syndrome	7.91e-07	8.94e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—JUN—epilepsy syndrome	7.91e-07	8.94e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—MTOR—epilepsy syndrome	7.9e-07	8.93e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AGT—epilepsy syndrome	7.9e-07	8.93e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AGT—epilepsy syndrome	7.9e-07	8.93e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL1B—epilepsy syndrome	7.89e-07	8.92e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	7.87e-07	8.89e-06	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—AKT1—epilepsy syndrome	7.86e-07	8.89e-06	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—AKT1—epilepsy syndrome	7.86e-07	8.89e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KDR—epilepsy syndrome	7.84e-07	8.86e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	7.83e-07	8.85e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—PTGS2—epilepsy syndrome	7.83e-07	8.85e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	7.77e-07	8.78e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—APOE—epilepsy syndrome	7.74e-07	8.75e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—APOE—epilepsy syndrome	7.74e-07	8.75e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	7.71e-07	8.72e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	7.69e-07	8.7e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—JUN—epilepsy syndrome	7.64e-07	8.64e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—MTOR—epilepsy syndrome	7.64e-07	8.64e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—MTOR—epilepsy syndrome	7.64e-07	8.64e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL1B—epilepsy syndrome	7.63e-07	8.62e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL1B—epilepsy syndrome	7.63e-07	8.62e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—AGT—epilepsy syndrome	7.58e-07	8.57e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KDR—epilepsy syndrome	7.58e-07	8.57e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KDR—epilepsy syndrome	7.58e-07	8.57e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—PTGS2—epilepsy syndrome	7.57e-07	8.56e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—PTGS2—epilepsy syndrome	7.57e-07	8.56e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	7.55e-07	8.53e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PRKCB—epilepsy syndrome	7.54e-07	8.53e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—ALB—epilepsy syndrome	7.54e-07	8.52e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	7.53e-07	8.52e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—ALB—epilepsy syndrome	7.53e-07	8.51e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6ST—epilepsy syndrome	7.51e-07	8.49e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—ALB—epilepsy syndrome	7.49e-07	8.47e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	7.46e-07	8.43e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	7.46e-07	8.43e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CAT—epilepsy syndrome	7.45e-07	8.42e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	7.44e-07	8.41e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—APOE—epilepsy syndrome	7.43e-07	8.4e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	7.43e-07	8.39e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—AGT—epilepsy syndrome	7.4e-07	8.36e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—JUN—epilepsy syndrome	7.39e-07	8.36e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—JUN—epilepsy syndrome	7.39e-07	8.36e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	7.32e-07	8.27e-06	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—AKT1—epilepsy syndrome	7.32e-07	8.27e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	7.31e-07	8.26e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PRKCB—epilepsy syndrome	7.3e-07	8.25e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PRKCB—epilepsy syndrome	7.3e-07	8.25e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6ST—epilepsy syndrome	7.27e-07	8.22e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6ST—epilepsy syndrome	7.27e-07	8.22e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—APOE—epilepsy syndrome	7.25e-07	8.2e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—ALB—epilepsy syndrome	7.25e-07	8.19e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—ALB—epilepsy syndrome	7.25e-07	8.19e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	7.25e-07	8.19e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	7.19e-07	8.12e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	7.16e-07	8.09e-06	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	7.16e-07	8.09e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	7.1e-07	8.02e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—SRC—epilepsy syndrome	7.09e-07	8.02e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	7.08e-07	8.01e-06	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—AKT1—epilepsy syndrome	7.08e-07	8e-06	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—AKT1—epilepsy syndrome	7.08e-07	8e-06	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—AKT1—epilepsy syndrome	7.03e-07	7.94e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	7.01e-07	7.92e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—TH—epilepsy syndrome	6.98e-07	7.89e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	6.98e-07	7.88e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AGT—epilepsy syndrome	6.97e-07	7.88e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	6.91e-07	7.81e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—RELA—epilepsy syndrome	6.91e-07	7.81e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	6.89e-07	7.79e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—POMC—epilepsy syndrome	6.87e-07	7.77e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—SRC—epilepsy syndrome	6.86e-07	7.75e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—APOE—epilepsy syndrome	6.83e-07	7.72e-06	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—AKT1—epilepsy syndrome	6.8e-07	7.68e-06	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—AKT1—epilepsy syndrome	6.8e-07	7.68e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	6.8e-07	7.68e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—RELA—epilepsy syndrome	6.78e-07	7.66e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	6.77e-07	7.66e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—GPX1—epilepsy syndrome	6.74e-07	7.61e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCL2—epilepsy syndrome	6.72e-07	7.6e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	6.71e-07	7.58e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	6.67e-07	7.54e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	6.66e-07	7.53e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	6.65e-07	7.52e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—POMC—epilepsy syndrome	6.65e-07	7.51e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—POMC—epilepsy syndrome	6.65e-07	7.51e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—SRC—epilepsy syndrome	6.63e-07	7.5e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—SRC—epilepsy syndrome	6.63e-07	7.5e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	6.6e-07	7.46e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	6.58e-07	7.44e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PTGS2—epilepsy syndrome	6.56e-07	7.41e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	6.54e-07	7.4e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCL2—epilepsy syndrome	6.5e-07	7.35e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCL2—epilepsy syndrome	6.5e-07	7.35e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	6.5e-07	7.35e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—POMC—epilepsy syndrome	6.38e-07	7.21e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTGS2—epilepsy syndrome	6.34e-07	7.17e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTGS2—epilepsy syndrome	6.34e-07	7.17e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—SRC—epilepsy syndrome	6.33e-07	7.16e-06	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	6.29e-07	7.11e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	6.23e-07	7.04e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—POMC—epilepsy syndrome	6.23e-07	7.04e-06	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	6.19e-07	6.99e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	6.18e-07	6.99e-06	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.17e-07	6.98e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	6.13e-07	6.93e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—SRC—epilepsy syndrome	6.12e-07	6.92e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—SRC—epilepsy syndrome	6.12e-07	6.92e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	6.12e-07	6.91e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—FGF2—epilepsy syndrome	6.08e-07	6.87e-06	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	6.07e-07	6.87e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—JUN—epilepsy syndrome	6.05e-07	6.84e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	6.02e-07	6.81e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	6.02e-07	6.8e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	5.95e-07	6.73e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—JUN—epilepsy syndrome	5.94e-07	6.71e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AGT—epilepsy syndrome	5.91e-07	6.68e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	5.89e-07	6.65e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—FGF2—epilepsy syndrome	5.88e-07	6.64e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—FGF2—epilepsy syndrome	5.88e-07	6.64e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—POMC—epilepsy syndrome	5.87e-07	6.63e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	5.85e-07	6.61e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.83e-07	6.59e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ALB—epilepsy syndrome	5.82e-07	6.58e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	5.79e-07	6.55e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—APOE—epilepsy syndrome	5.79e-07	6.54e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	5.78e-07	6.53e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CAT—epilepsy syndrome	5.75e-07	6.5e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	5.71e-07	6.45e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	5.69e-07	6.43e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ALB—epilepsy syndrome	5.68e-07	6.42e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—RELA—epilepsy syndrome	5.64e-07	6.38e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	5.62e-07	6.35e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	5.61e-07	6.34e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	5.59e-07	6.32e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MTOR—epilepsy syndrome	5.53e-07	6.25e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	5.52e-07	6.23e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—RELA—epilepsy syndrome	5.46e-07	6.17e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—RELA—epilepsy syndrome	5.46e-07	6.17e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—SRC—epilepsy syndrome	5.43e-07	6.13e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MTOR—epilepsy syndrome	5.35e-07	6.05e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MTOR—epilepsy syndrome	5.35e-07	6.05e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ALB—epilepsy syndrome	5.35e-07	6.05e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	5.34e-07	6.04e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—SRC—epilepsy syndrome	5.33e-07	6.02e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	5.29e-07	5.98e-06	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	5.27e-07	5.95e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	5.24e-07	5.93e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	5.2e-07	5.88e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	5.2e-07	5.88e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	5.19e-07	5.87e-06	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	5.19e-07	5.87e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	5.11e-07	5.77e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	5.09e-07	5.75e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CASP3—epilepsy syndrome	5.09e-07	5.75e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—POMC—epilepsy syndrome	4.97e-07	5.62e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTGS2—epilepsy syndrome	4.97e-07	5.62e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—JUN—epilepsy syndrome	4.94e-07	5.59e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CASP3—epilepsy syndrome	4.92e-07	5.56e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CASP3—epilepsy syndrome	4.92e-07	5.56e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MMP9—epilepsy syndrome	4.81e-07	5.43e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—JUN—epilepsy syndrome	4.78e-07	5.4e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—JUN—epilepsy syndrome	4.78e-07	5.4e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	4.68e-07	5.29e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—AKT1—epilepsy syndrome	4.66e-07	5.27e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MMP9—epilepsy syndrome	4.65e-07	5.26e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MMP9—epilepsy syndrome	4.65e-07	5.26e-06	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—AKT1—epilepsy syndrome	4.58e-07	5.17e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AGT—epilepsy syndrome	4.56e-07	5.15e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ALB—epilepsy syndrome	4.53e-07	5.12e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—AKT1—epilepsy syndrome	4.51e-07	5.1e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—AKT1—epilepsy syndrome	4.51e-07	5.1e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—APOE—epilepsy syndrome	4.47e-07	5.05e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	4.45e-07	5.03e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SRC—epilepsy syndrome	4.43e-07	5.01e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	4.41e-07	4.98e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—epilepsy syndrome	4.32e-07	4.88e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SRC—epilepsy syndrome	4.29e-07	4.85e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SRC—epilepsy syndrome	4.29e-07	4.85e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—AKT1—epilepsy syndrome	4.26e-07	4.82e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—epilepsy syndrome	4.18e-07	4.72e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—epilepsy syndrome	4.18e-07	4.72e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—AKT1—epilepsy syndrome	4.12e-07	4.66e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—AKT1—epilepsy syndrome	4.12e-07	4.66e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	3.97e-07	4.48e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—AKT1—epilepsy syndrome	3.93e-07	4.45e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	3.84e-07	4.34e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.84e-07	4.34e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—AKT1—epilepsy syndrome	3.81e-07	4.3e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—AKT1—epilepsy syndrome	3.81e-07	4.3e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.5e-07	3.95e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	3.37e-07	3.81e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	3.32e-07	3.75e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—AKT1—epilepsy syndrome	3.32e-07	3.75e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	3.31e-07	3.74e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—AKT1—epilepsy syndrome	3.31e-07	3.74e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—AKT1—epilepsy syndrome	3.29e-07	3.72e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	3.26e-07	3.68e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—AKT1—epilepsy syndrome	3.19e-07	3.6e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—AKT1—epilepsy syndrome	3.19e-07	3.6e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.06e-07	3.46e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKT1—epilepsy syndrome	2.76e-07	3.11e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT1—epilepsy syndrome	2.67e-07	3.01e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT1—epilepsy syndrome	2.67e-07	3.01e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—AKT1—epilepsy syndrome	2.56e-07	2.89e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.5e-07	2.82e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.35e-07	2.66e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.99e-07	2.25e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.54e-07	1.74e-06	CbGpPWpGaD
